InvestorsHub Logo

abew4me

08/28/23 10:08 AM

#428700 RE: bas2020 #428685

Fully agree. As further proof that Anavex is preparing for commercialization, Just look at how they've restructured their chain of command by hiring Dr. Kun Jin as Vice President Head of Biostatistics....and promoting Dr. Jiong Ma to Chairman of the Board. (See below)

Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as VP Head of Biostatistics

https://www.anavex.com/post/anavex-life-sciences-appoints-former-fda-lead-neurology-statistician-as-vp-head-of-biostatistics


Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors

https://chavantcapital.com/team/dr-jiong-ma/

https://finance.yahoo.com/news/anavex-life-sciences-announces-appointment-110000415.html?fr=sycsrp_catchall

sab63090

08/28/23 10:16 AM

#428703 RE: bas2020 #428685

bas2020
Makes sense to me....

Joseph_K

08/28/23 4:36 PM

#428747 RE: bas2020 #428685

I agree with you about the AD OLE comment indicating his positive outlook on AD approval. As for commercialization, that can be justified by optimism about Rett by itself, especially as Missling's plans for Rett will require a lot more commercial activity than his Alzheimer's plans.

ExtremelyBullishZig

08/28/23 8:08 PM

#428768 RE: bas2020 #428685

Sure he would.